why choose us

Clinical Trials Search

Showing 12,660 of 132,366 result(s)
Endoscopic Ultrasound-guided Radiofrequency Ablation of Pancreatic Cysts (ERASE)

Status: Completed

Condition: Pancreatic Cyst

Interventions: EUS-RFA is performed with an 19 Gauge RFA needle (STARMed;TaeWoong Medical USA) applying up to 30 Watt (W) current with Continuance Mode setting.

Date: 2023-04-26

Direct Access Carotid Artery Stenting Using the Neuroguard IEP System (PERFORMANCE III)

Status: Completed

Condition: Carotid Stenosis

Interventions: carotid artery stenting, direct access with blood flow redirection

Date: 2023-04-26

Diagnostic Performance of Small RNA Blood Test in Patients Undergoing Follow-up Imaging After Positive Low Dose CT Screening for Cancer of the Lung

Status: Completed

Condition: Lung Cancer

Interventions: At study enrollment a blood sample will be drawn prior to any invasive diagnostic study or treatment.
On this blood sample a novel lung cancer te

Date: 2023-04-26

Evaluating a Potential Pharmacokinetic Kratom-oxycodone Interaction Concurrent With Clinical Endpoints

Status: Completed

Condition: Herbal Interaction

Interventions: Kratom (Moon Kratom Yellow Indonesian, lot 51) is supplied as a dry leaf powder in clear plastic bags, each weighing 5 kg.
Two grams of kratom dr

Date: 2023-04-26

Little Cigar and Cigarillo Warnings Among US Adults Who Use LCCs

Status: COMPLETED

Condition: Tobacco Use

Interventions: On study days 1-6, 8-13 and 15-20, participants in this condition will view an image of a little cigar and cigarillo package with a warning developed

Date: 2023-04-26

The Technical and Operational Performance of the QuidelOrtho Savanna RVP4 Analyzer

Status: COMPLETED

Condition: Respiratory Viral Infection

Interventions:

Date: 2023-04-26

Pharmacokinetics, Pharmacodynamics and Safety of Epeleuton in Patients With Sickle Cell Disease

Status: Completed

Condition: Sickle Cell Disease

Interventions: Participants will receive 2000mg Epeleuton (DS102) capsules twice daily.

Date: 2023-04-26

(2R,6R)-Hydroxynorketamine for the Treatment of Neuropathic Pain

Status: NOT_YET_RECRUITING

Condition: Pain, Neuropathic

Interventions: Ketamine will be administered over a 45-minute period.

Date: 2023-04-26

A Collaborative Community Effort Using Belantamab Mafodotin in Relapsed;Refractory Myeloma

Status: NOT_YET_RECRUITING

Condition: Relapsed;Refractory Multiple Myeloma

Interventions: Belantamab mafodotin 2.5mg;kg in 42-day cycles.
Every 6 weeks until PD, unacceptable toxicity or withdrawal of consent, whichever comes firs

Date: 2023-04-26